SKIN
SkinHealth Systems Inc.
Price Chart
Latest Quote
$0.66
+0.01 (+1.98%)
Current Price
| Previous Close | $0.65 |
| Open | $0.67 |
| Day High | $0.70 |
| Day Low | $0.66 |
| Volume | 690,380 |
Stock Information
| Shares Outstanding | 129.60M |
| Total Debt | $367.13M |
| Cash Equivalents | $202.36M |
| Revenue | $296.12M |
| Net Income | $-6.54M |
| Sector | Consumer Defensive |
| Industry | Household & Personal Products |
| Market Cap | $85.90M |
| EPS (TTM) | $-0.13 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $249.43M |
| Sales | $296.12M |
| Income | $-6.54M |
| Book/sh | $0.48 |
| Cash/sh | $1.56 |
| Employees | 613 |
Financial Ratios
| Quick Ratio | 1.43 |
| Current Ratio | 1.79 |
| Debt/Eq | 664.61 |
Returns & Margins
| ROA | -1.15% |
| ROE | -11.95% |
| Gross Margin | 64.91% |
| Operating Margin | -2.77% |
| Profit Margin | -2.04% |
Ownership
| Insider Ownership | 13.19% |
| Institutional Ownership | 87.91% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 4.42 |
| PEG | 0.93 |
| P/S | 0.29 |
| P/B | 1.38 |
Analyst Data
| Recommendation | none |
| Target Price | $1.34 |
Technical Indicators
| SMA20 | $0.68 |
| SMA50 | $0.76 |
| SMA200 | $1.27 |
| RSI | 29.96 |
| ATR | 0.0518 |
| Shares Float | 65.01M |
| Short Float | 30.12% |
| Short Ratio | 9.06 |
| Volatility | 1.07 |
| Rel Volume | 0.91 |
Performance History
| Week | +3.27% |
| Month | +0.00% |
| Quarter | -42.84% |
| 6 Months | -52.98% |
| YTD | -52.64% |
| Year | -56.67% |
| 3 Years | -93.03% |
| 5 Years | -96.17% |
| 10 Years | -93.88% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.66 | 869,500 |
| 2026-06-17 | $0.65 | 644,600 |
| 2026-06-16 | $0.65 | 305,400 |
| 2026-06-15 | $0.65 | 491,900 |
| 2026-06-12 | $0.65 | 390,200 |
| 2026-06-11 | $0.64 | 646,000 |
| 2026-06-10 | $0.67 | 402,700 |
| 2026-06-09 | $0.63 | 453,600 |
| 2026-06-08 | $0.63 | 756,900 |
| 2026-06-05 | $0.61 | 955,700 |
| 2026-06-04 | $0.61 | 745,100 |
| 2026-06-03 | $0.63 | 791,600 |
| 2026-06-02 | $0.67 | 832,700 |
| 2026-06-01 | $0.70 | 605,300 |
| 2026-05-29 | $0.77 | 1,870,100 |
| 2026-05-28 | $0.79 | 809,400 |
| 2026-05-27 | $0.78 | 1,280,700 |
| 2026-05-26 | $0.86 | 4,320,300 |
| 2026-05-22 | $0.69 | 873,600 |
| 2026-05-21 | $0.66 | 1,119,000 |
| 2026-05-20 | $0.68 | 1,251,400 |
| 2026-05-19 | $0.66 | 1,464,400 |
About SkinHealth Systems Inc.
SkinHealth Systems Inc., a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions in the Americas, the Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. The company's flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers, as well as offers boosters. The company was formerly known as The Beauty Health Company and changed its name to SkinHealth Systems Inc. in April 2026. The company was founded in 1997 and is headquartered in Long Beach, California.
đ° Latest News
Strata Critical Medical, Inc. (SRTA) Surges 8.5%: Is This an Indication of Further Gains?
Zacks âĸ 2026-06-16T12:14:00Z
How The Investment Story For SkinHealth Systems (SKIN) Is Shifting After Guidance And Fair Value Reset
Simply Wall St. âĸ 2026-06-07T22:08:35Z
Why SkinHealth Systems Inc. (SKIN) International Revenue Trends Deserve Your Attention
Zacks âĸ 2026-05-12T13:15:02Z
Beauty Health Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-09T02:05:45Z
SkinHealth Systems Inc. (SKIN) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-07T23:05:21Z
Compared to Estimates, SkinHealth Systems Inc. (SKIN) Q1 Earnings: A Look at Key Metrics
Zacks âĸ 2026-05-07T22:30:03Z
Consumer Staples Arenât So Defensive Anymore. Even Grocery Outlet and BellRing Are Volatile.
Barrons.com âĸ 2026-04-28T20:14:00Z
How The Beauty Health (SKIN) Investment Story Is Shifting With Mixed Analyst Signals
Simply Wall St. âĸ 2026-04-09T00:20:13Z
Why The Beauty Health Story Is Shifting As Analysts Rework Targets And FY26 EBITDA Expectations
Simply Wall St. âĸ 2026-03-25T04:31:25Z
Don't Overlook Beauty Health (SKIN) International Revenue Trends While Assessing the Stock
Zacks âĸ 2026-03-17T13:15:01Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $104,426,000 | $151,998,000 | $242,878,000 | $117,097,000 |
| Cost Of Revenue | $104,426,000 | $151,998,000 | $242,878,000 | $117,097,000 |
| Total Revenue | $300,790,000 | $334,294,000 | $397,991,000 | $365,876,000 |
| Operating Revenue | $300,790,000 | $334,294,000 | $397,991,000 | $365,876,000 |
| Expenses | ||||
| Interest Expense | $19,326,000 | $10,412,000 | $13,649,000 | $13,392,000 |
| Total Expenses | $321,593,000 | $402,068,000 | $528,908,000 | $391,717,000 |
| Other Income Expense | $25,237,000 | $31,992,000 | $19,504,000 | $75,397,000 |
| Other Non Operating Income Expenses | $18,931,000 | $33,563,000 | $5,200,000 | $-1,650,000 |
| Net Non Operating Interest Income Expense | $-10,372,000 | $6,232,000 | $9,524,000 | $-4,217,000 |
| Interest Expense Non Operating | $19,326,000 | $10,412,000 | $13,649,000 | $13,392,000 |
| Operating Expense | $217,167,000 | $250,070,000 | $286,030,000 | $274,620,000 |
| Selling And Marketing Expense | $93,590,000 | $118,311,000 | $144,496,000 | $160,076,000 |
| General And Administrative Expense | $117,949,000 | $125,463,000 | $131,432,000 | $106,100,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Net Interest Income | $-10,372,000 | $6,232,000 | $9,524,000 | $-4,217,000 |
| Interest Income | $8,954,000 | $16,644,000 | $23,173,000 | $9,175,000 |
| Normalized Income | $-14,500,740 | $-27,550,565 | $-114,171,092 | $-30,973,872 |
| Net Income From Continuing And Discontinued Operation | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Total Operating Income As Reported | $-20,803,000 | $-67,774,000 | $-130,917,000 | $-25,841,000 |
| Average Dilution Earnings | $-12,590,000 | $-22,671,000 | $0 | $-78,343,000 |
| Net Income Common Stockholders | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Net Income | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Net Income Including Noncontrolling Interests | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Net Income Continuous Operations | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Pretax Income | $-5,938,000 | $-29,550,000 | $-101,889,000 | $45,339,000 |
| Interest Income Non Operating | $8,954,000 | $16,644,000 | $23,173,000 | $9,175,000 |
| Operating Income | $-20,803,000 | $-67,774,000 | $-130,917,000 | $-25,841,000 |
| Gross Profit | $196,364,000 | $182,296,000 | $155,113,000 | $248,779,000 |
| Per Share | ||||
| Diluted EPS | $-0.16 | $-0.23 | $-0.76 | $0.23 |
| Basic EPS | $-0.08 | $-0.23 | $-0.76 | $0.30 |
| Other | ||||
| Tax Effect Of Unusual Items | $1,324,260 | $-23,565 | $248,908 | $1,849,128 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $32,431,000 | $16,113,000 | $-67,869,000 | $4,557,000 |
| Total Unusual Items | $6,306,000 | $-1,571,000 | $14,304,000 | $77,047,000 |
| Total Unusual Items Excluding Goodwill | $6,306,000 | $-1,571,000 | $14,304,000 | $77,047,000 |
| Reconciled Depreciation | $25,349,000 | $33,680,000 | $34,675,000 | $22,873,000 |
| EBITDA (Bullshit earnings) | $38,737,000 | $14,542,000 | $-53,565,000 | $81,604,000 |
| EBIT | $13,388,000 | $-19,138,000 | $-88,240,000 | $58,731,000 |
| Diluted Average Shares | $135,798,202 | $123,827,372 | $131,680,605 | $148,506,312 |
| Basic Average Shares | $126,378,509 | $123,827,372 | $131,680,605 | $147,554,090 |
| Diluted NI Availto Com Stockholders | $-22,109,000 | $-51,769,000 | $-100,116,000 | $-34,119,000 |
| Tax Provision | $3,581,000 | $-452,000 | $-1,773,000 | $1,115,000 |
| Gain On Sale Of Security | $6,306,000 | $-1,571,000 | $14,304,000 | $77,047,000 |
| Research And Development | $5,628,000 | $6,296,000 | $10,102,000 | $8,444,000 |
| Selling General And Administration | $211,539,000 | $243,774,000 | $275,928,000 | $266,176,000 |
| Other Gand A | $117,949,000 | $125,463,000 | $131,432,000 | $106,100,000 |
Fetched: 2026-06-19
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-101,328,000 | $-119,208,000 | $-128,551,000 | $-3,926,000 |
| Total Assets | $499,803,000 | $685,683,000 | $929,113,000 | $1,003,083,000 |
| Total Non Current Assets | $190,286,000 | $208,559,000 | $230,861,000 | $219,808,000 |
| Other Non Current Assets | $11,869,000 | $14,086,000 | $16,043,000 | $14,193,000 |
| Non Current Deferred Assets | $1,925,000 | $3,894,000 | $531,000 | $815,000 |
| Non Current Deferred Taxes Assets | $1,925,000 | $3,894,000 | $531,000 | $815,000 |
| Goodwill And Other Intangible Assets | $162,384,000 | $171,011,000 | $187,941,000 | $170,979,000 |
| Other Intangible Assets | $35,763,000 | $47,512,000 | $62,123,000 | $46,386,000 |
| Current Assets | $309,517,000 | $477,124,000 | $698,252,000 | $783,275,000 |
| Other Current Assets | $5,395,000 | $9,487,000 | $28,877,000 | $27,648,000 |
| Inventory | $48,012,000 | $69,113,000 | $91,321,000 | $109,656,000 |
| Receivables | $23,437,000 | $28,461,000 | $55,029,000 | $77,774,000 |
| Taxes Receivable | $1,696,000 | $818,000 | $332,000 | $1,280,000 |
| Accounts Receivable | $21,741,000 | $27,643,000 | $54,697,000 | $76,494,000 |
| Allowance For Doubtful Accounts Receivable | $-6,022,000 | $-9,597,000 | $-6,604,000 | $-2,929,000 |
| Gross Accounts Receivable | $27,763,000 | $37,240,000 | $61,301,000 | $79,423,000 |
| Cash Cash Equivalents And Short Term Investments | $232,673,000 | $370,063,000 | $523,025,000 | $568,197,000 |
| Cash And Cash Equivalents | $232,673,000 | $370,063,000 | $523,025,000 | $568,197,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $131,717,000 | $182,135,000 | $215,347,000 | $165,946,000 |
| Total Debt | $378,756,000 | $568,158,000 | $752,289,000 | $751,790,000 |
| Long Term Debt And Capital Lease Obligation | $249,669,000 | $563,011,000 | $747,691,000 | $746,832,000 |
| Long Term Debt | $240,431,000 | $552,198,000 | $738,372,000 | $734,143,000 |
| Current Debt And Capital Lease Obligation | $129,087,000 | $5,147,000 | $4,598,000 | $4,958,000 |
| Current Debt | $123,959,000 | - | - | - |
| Other Current Borrowings | $123,959,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $438,747,000 | $633,880,000 | $869,723,000 | $836,030,000 |
| Total Non Current Liabilities Net Minority Interest | $252,472,000 | $565,728,000 | $754,715,000 | $764,316,000 |
| Other Non Current Liabilities | $2,410,000 | $2,321,000 | $2,767,000 | $15,473,000 |
| Non Current Deferred Liabilities | $393,000 | $396,000 | $702,000 | $2,011,000 |
| Non Current Deferred Taxes Liabilities | $393,000 | $396,000 | $702,000 | $2,011,000 |
| Current Liabilities | $186,275,000 | $68,152,000 | $115,008,000 | $71,714,000 |
| Current Deferred Liabilities | $1,012,000 | $2,375,000 | $450,000 | - |
| Payables And Accrued Expenses | $53,925,000 | $58,486,000 | $84,946,000 | $61,113,000 |
| Interest Payable | $2,929,000 | $1,743,000 | $2,344,000 | $2,344,000 |
| Payables | $38,333,000 | $41,319,000 | $62,956,000 | $42,130,000 |
| Total Tax Payable | $22,702,000 | $19,378,000 | $18,188,000 | $11,844,000 |
| Income Tax Payable | $1,226,000 | $3,426,000 | $2,759,000 | $1,429,000 |
| Accounts Payable | $15,631,000 | $21,941,000 | $44,768,000 | $28,467,000 |
| Derivative Product Liabilities | - | $488,000 | $3,555,000 | $15,473,000 |
| Other Payable | - | - | - | $1,819,000 |
| Equity | ||||
| Common Stock Equity | $61,056,000 | $51,803,000 | $59,390,000 | $167,053,000 |
| Total Equity Gross Minority Interest | $61,056,000 | $51,803,000 | $59,390,000 | $167,053,000 |
| Stockholders Equity | $61,056,000 | $51,803,000 | $59,390,000 | $167,053,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,434,000 | $-6,953,000 | $-3,036,000 | $-4,530,000 |
| Other Equity Adjustments | $-1,434,000 | $-6,953,000 | $-3,036,000 | $-4,530,000 |
| Retained Earnings | $-517,484,000 | $-507,965,000 | $-478,867,000 | $-378,751,000 |
| Other | ||||
| Ordinary Shares Number | $127,520,823 | $124,924,185 | $122,899,002 | $132,214,695 |
| Share Issued | $127,520,823 | $124,924,185 | $122,899,002 | $132,214,695 |
| Tangible Book Value | $-101,328,000 | $-119,208,000 | $-128,551,000 | $-3,926,000 |
| Invested Capital | $425,446,000 | $604,001,000 | $797,762,000 | $901,196,000 |
| Working Capital | $123,242,000 | $408,972,000 | $583,244,000 | $711,561,000 |
| Capital Lease Obligations | $14,366,000 | $15,960,000 | $13,917,000 | $17,647,000 |
| Total Capitalization | $301,487,000 | $604,001,000 | $797,762,000 | $901,196,000 |
| Additional Paid In Capital | $579,961,000 | $566,709,000 | $541,281,000 | $550,320,000 |
| Capital Stock | $13,000 | $12,000 | $12,000 | $14,000 |
| Common Stock | $13,000 | $12,000 | $12,000 | $14,000 |
| Long Term Capital Lease Obligation | $9,238,000 | $10,813,000 | $9,319,000 | $12,689,000 |
| Current Deferred Revenue | $1,012,000 | $2,375,000 | $450,000 | - |
| Current Capital Lease Obligation | $5,128,000 | $5,147,000 | $4,598,000 | $4,958,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $2,251,000 | $2,144,000 | $4,005,000 | $5,643,000 |
| Current Accrued Expenses | $15,592,000 | $17,167,000 | $21,990,000 | $18,983,000 |
| Goodwill | $126,621,000 | $123,499,000 | $125,818,000 | $124,593,000 |
| Net PPE | $14,108,000 | $19,568,000 | $26,346,000 | $33,821,000 |
| Accumulated Depreciation | $-22,798,000 | $-25,500,000 | $-19,953,000 | $-12,494,000 |
| Gross PPE | $36,906,000 | $45,068,000 | $46,299,000 | $46,315,000 |
| Leases | $11,080,000 | $12,019,000 | $12,323,000 | $11,812,000 |
| Construction In Progress | $55,000 | $0 | $748,000 | $1,375,000 |
| Other Properties | $12,111,000 | $14,322,000 | $13,007,000 | $16,275,000 |
| Machinery Furniture Equipment | $13,660,000 | $18,727,000 | $20,221,000 | $16,853,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $29,466,000 | $43,094,000 | $66,915,000 | $71,283,000 |
| Raw Materials | $18,546,000 | $26,019,000 | $24,406,000 | $38,373,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Provisions | - | - | $21,009,000 | - |
| Preferred Stock | - | - | - | $0 |
Fetched: 2026-06-19
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $32,322,000 | $9,340,000 | $8,701,000 | $-123,994,000 |
| Operating Activities | ||||
| Operating Cash Flow | $37,485,000 | $16,134,000 | $21,750,000 | $-106,600,000 |
| Cash Flow From Continuing Operating Activities | $37,485,000 | $16,134,000 | $21,750,000 | $-106,600,000 |
| Operating Gains Losses | $-487,000 | $-3,067,000 | $-11,919,000 | $-78,343,000 |
| Investing Activities | ||||
| Capital Expenditure | $-5,163,000 | $-6,794,000 | $-13,049,000 | $-17,394,000 |
| Investing Cash Flow | $-5,163,000 | $-6,794,000 | $-31,507,000 | $-18,869,000 |
| Cash Flow From Continuing Investing Activities | $-5,163,000 | $-6,794,000 | $-31,507,000 | $-18,869,000 |
| Net Other Investing Changes | - | - | $-18,458,000 | $-1,475,000 |
| Capital Expenditure Reported | - | - | - | $-17,394,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $0 | $0 | $-32,395,000 | $-160,000,000 |
| Financing Cash Flow | $-174,926,000 | $-158,341,000 | $-37,448,000 | $-205,242,000 |
| Cash Flow From Continuing Financing Activities | $-174,926,000 | $-158,341,000 | $-37,448,000 | $-205,242,000 |
| Net Other Financing Charges | $-1,572,000 | $-2,259,000 | $-5,053,000 | $-45,242,000 |
| Net Common Stock Issuance | $0 | $0 | $-32,395,000 | $-160,000,000 |
| Other | ||||
| Repayment Of Debt | $-410,955,000 | $-156,082,000 | $0 | $0 |
| Issuance Of Debt | $237,601,000 | $0 | $0 | $0 |
| Interest Paid Supplemental Data | $14,440,000 | $8,014,000 | $9,375,000 | $9,818,000 |
| End Cash Position | $232,673,000 | $370,063,000 | $523,025,000 | $568,197,000 |
| Beginning Cash Position | $370,063,000 | $523,025,000 | $568,197,000 | $901,886,000 |
| Effect Of Exchange Rate Changes | $5,214,000 | $-3,961,000 | $2,033,000 | $-2,978,000 |
| Changes In Cash | $-142,604,000 | $-149,001,000 | $-47,205,000 | $-330,711,000 |
| Common Stock Payments | $0 | $0 | $-32,395,000 | $-160,000,000 |
| Net Issuance Payments Of Debt | $-173,354,000 | $-156,082,000 | $0 | $0 |
| Net Long Term Debt Issuance | $-173,354,000 | $-156,082,000 | $0 | $0 |
| Long Term Debt Payments | $-410,955,000 | $-156,082,000 | $0 | $0 |
| Long Term Debt Issuance | $237,601,000 | $0 | $0 | $0 |
| Net Intangibles Purchase And Sale | $-4,860,000 | $-6,038,000 | $-9,224,000 | $-6,547,000 |
| Purchase Of Intangibles | $-4,860,000 | $-6,038,000 | $-9,224,000 | $-6,547,000 |
| Net PPE Purchase And Sale | $-303,000 | $-756,000 | $-3,825,000 | $-10,847,000 |
| Purchase Of PPE | $-303,000 | $-756,000 | $-3,825,000 | $-10,847,000 |
| Change In Working Capital | $10,373,000 | $-27,393,000 | $23,356,000 | $-145,267,000 |
| Change In Other Working Capital | $-6,825,000 | $-9,400,000 | $-7,597,000 | $-12,078,000 |
| Change In Payables And Accrued Expense | $-7,179,000 | $-43,776,000 | $44,001,000 | $-2,954,000 |
| Change In Prepaid Assets | $3,423,000 | $15,479,000 | $-6,951,000 | $-13,847,000 |
| Change In Inventory | $15,792,000 | $-10,500,000 | $-22,617,000 | $-84,363,000 |
| Change In Receivables | $5,162,000 | $20,804,000 | $16,520,000 | $-32,025,000 |
| Changes In Account Receivables | $5,162,000 | $20,804,000 | $16,520,000 | $-32,025,000 |
| Other Non Cash Items | $-14,560,000 | $-14,111,000 | $11,296,000 | $16,439,000 |
| Stock Based Compensation | $14,824,000 | $26,696,000 | $22,544,000 | $28,495,000 |
| Provisionand Write Offof Assets | $2,067,000 | $5,134,000 | $5,153,000 | $1,622,000 |
| Asset Impairment Charge | $7,219,000 | $28,041,000 | $37,840,000 | $5,144,000 |
| Deferred Tax | $2,219,000 | $-3,748,000 | $-1,079,000 | $-1,787,000 |
| Deferred Income Tax | $2,219,000 | $-3,748,000 | $-1,079,000 | $-1,787,000 |
| Depreciation Amortization Depletion | $25,349,000 | $33,680,000 | $34,675,000 | $22,873,000 |
| Depreciation And Amortization | $25,349,000 | $33,680,000 | $34,675,000 | $22,873,000 |
| Amortization Cash Flow | $21,501,000 | $23,740,000 | $23,343,000 | $15,709,000 |
| Amortization Of Intangibles | $21,501,000 | $23,740,000 | $23,343,000 | $15,709,000 |
| Depreciation | $3,848,000 | $9,940,000 | $11,332,000 | $7,164,000 |
| Gain Loss On Investment Securities | $-487,000 | $-3,067,000 | $-11,919,000 | $-78,343,000 |
| Net Income From Continuing Operations | $-9,519,000 | $-29,098,000 | $-100,116,000 | $44,224,000 |
| Income Tax Paid Supplemental Data | - | $2,801,000 | $2,269,000 | - |
| Proceeds From Stock Option Exercised | - | - | $0 | $0 |
| Net Short Term Debt Issuance | - | - | $0 | $0 |
| Short Term Debt Payments | - | - | $0 | $0 |
| Short Term Debt Issuance | - | - | $0 | $0 |
| Net Business Purchase And Sale | - | - | $0 | $0 |
| Purchase Of Business | - | - | $0 | $0 |
| Change In Accrued Expense | - | - | $26,936,000 | $-3,357,000 |
| Change In Payable | - | - | $17,065,000 | $1,804,000 |
| Change In Account Payable | - | - | $15,783,000 | $1,606,000 |
| Change In Tax Payable | - | - | $1,282,000 | $198,000 |
| Change In Income Tax Payable | - | - | $1,282,000 | $198,000 |
| Change In Other Current Liabilities | - | - | - | $-4,033,000 |
| Change In Other Current Assets | - | - | - | $-8,045,000 |
| Net Foreign Currency Exchange Gain Loss | - | - | - | $2,410,000 |
| Gain Loss On Sale Of PPE | - | - | - | $5,239,000 |
Fetched: 2026-06-19